Health Care & Life Sciences » Biotechnology | Calithera Biosciences Inc.

Calithera Biosciences Inc.

Calithera Biosciences Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
35.99 M
Public Float
26.24 M
Calithera Biosciences Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.73
Market Cap
$175.8 M
Shares Outstanding
51.74 M
Public Float
33.08 M

Profile

Address
343 Oyster Point Boulevard
South San Francisco California 94080
United States
Employees -
Website http://www.calithera.com
Updated 07/08/2019
Calithera Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. It offers programs such as Pipeline, Glutaminase Inhibitor, and Arginase Inhibitor. The company was founded by James A.

Financials

View All

Susan M. Molineaux
President, Chief Executive Officer & Director
Blake Wise
Independent Director